1. Home
  2. KPTI vs NCSM Comparison

KPTI vs NCSM Comparison

Compare KPTI & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$8.63

Market Cap

194.8M

Sector

Health Care

ML Signal

HOLD

Logo NCS Multistage Holdings Inc.

NCSM

NCS Multistage Holdings Inc.

HOLD

Current Price

$41.12

Market Cap

170.3M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
KPTI
NCSM
Founded
2008
2006
Country
United States
United States
Employees
228
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oilfield Services/Equipment
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
194.8M
170.3M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
KPTI
NCSM
Price
$8.63
$41.12
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$16.00
N/A
AVG Volume (30 Days)
403.3K
38.3K
Earning Date
05-04-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
239.22
EPS
N/A
N/A
Revenue
$146,067,000.00
$142,471,000.00
Revenue This Year
N/A
$5.57
Revenue Next Year
$22.36
$4.81
P/E Ratio
N/A
N/A
Revenue Growth
0.57
N/A
52 Week Low
$3.65
$28.65
52 Week High
$10.99
$87.36

Technical Indicators

Market Signals
Indicator
KPTI
NCSM
Relative Strength Index (RSI) 52.53 29.75
Support Level $8.11 $35.23
Resistance Level $9.00 $43.62
Average True Range (ATR) 0.58 6.06
MACD -0.03 -4.31
Stochastic Oscillator 33.12 5.70

Price Performance

Historical Comparison
KPTI
NCSM

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completion, and field development strategies. The company provides its products and services to E&P companies for use in onshore and offshore wells, predominantly those drilled with horizontal laterals in unconventional and conventional oil and natural gas formations. It also provides tracer diagnostics services and sells products for well construction including casing buoyancy systems, liner hanger systems and toe initiation sleeves, along with certain complementary products from third parties. The company operates in the United States, Canada and other countries, with the majority of its revenue generated from Canada.

Share on Social Networks: